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Chapter X
STREPTOMYCIN
Streptomycin was one of the major medical discoveries of this century.
Tuberculosis could now be cured. No longer had the patient to stay for months in
a sanatorium, where cure was by no means certain, even in early cases. Many
drugs were tried: creosote wasa favourite in early days, apparently because it was
excreted by the lungs and had an antiseptic sort ofsmell. Gold salts were used for
quite a long time with no good results. Certain chemical substances allied to
sulphanilamides seemed hopeful. Perhaps the most bizarre was insufflation ofthe
bowel with a mixture of carbon dioxide and sulphurated hydrogen. Penicillin
proved to be useless. The tubercle bacillus enclosed in a kind of waxy envelope
was immune to all these. It could affect not only the lungs but almost any organ in
the human body, the brain, the kidneys, the lymph glands, the bones, thejoints,
even the skin. No wonder Sir William Gull commented on the difficulty in
diagnosis.
The discovery of streptomycin in no way resembled that of penicillin, where a
spore of a particular variety of penicillium was blown in through an open window
in Fleming's laboratory and landed on a culture plate, to be noticed almost by
accident some time later. Streptomycin was discovered after the most intense
labour of a number of scientists, especially Selman A Waksman. It had been
known for a long time that there were certain organisms in the soil, called either
fungi or bacteria - depending on whether they were being described by a
mycologist or a bacteriologist - which had the property of inhibiting the growth
of, or killing, other bacteria.
One particular group of these organisms called actinomyces, which seemed
to be most efficient at surviving under adverse conditions, and in killing off its
neighbours, was first described in 1890 by Gasparini. He named the sample he
was studying streptothrix. Over the years other investigators wrote about the
properties of this fungus, but the foundation of our modern knowledge was laid
by Waksman. He was interested in the antibiotic properties which some of these
fungi possessed. There were some organisms that penicillin did not affect at all,
notably the tubercle bacillus, and there was a hope that this new antibiotic might
deal with it.
The first experiments began in the microbiology laboratory of the New Jersey
Agricultural Experimental Station in 1939. A strain of actinomyces was isolated,
the product of which they called actinomycin. This was a potent antibiotic but
very toxic to experimental animals. In all, Waksman isolated 244 cultures of
actinomyces. Finally two cultures were found, one from soil and the other from
the throat ofa chicken; both belonged to a strain ofactinomyces called A griseus,
which seemed to be what they were looking for. Waksman christened the new
antibiotic streptomycin when he announced his results in 1944.
After a great deal of work the molecular structure ofstreptomycin was elucidated
and the preparation of a chemical derivative began. By the end of 1947 sufficient
streptomycin had been manufactured to begin exporting it. There was an
explosion of interest when streptomycin became generally available and in thefive years following its isolation in 1943, 1,800 papers were published about the
results obtained with it. In Northern Ireland clinical trials were carried out by
Dr J N White in the Whiteabbey Sanatorium, and he reported on the best ways of
using this potent remedy.
Rest and adequate nutrition were all a sanatorium could offer, and certain surgical
techniques were evolved with the aim of putting the affected lung at rest. The
nerves supplying the diaphragm were readily accessible in the neck, and one
nerve was divided so that the diaphragm on the side it served would be paralysed,
and the lung would not fill with air during breathing. Another method called
pneumothorax was to inject air into the chest cavity so that the lung on that side
collapsed. This procedure had to be repeated at intervals as the air absorbed.
A more drastic operation entailed removing a portion of several ribs so that the
lung would be premanently collapsed. These operations were carried out in
Belfast by that quite remarkable surgeon, Mr G B Purce, who pioneered not only
chest surgery in the Province, but brain surgery also, this on top of his general
surgical activities. He must have had an enormous work load.
The introduction of streptomycin had a dramatic effect on the treatment of all
types of tuberculosis. Tuberculous meningitis, previously invariably fatal, could
now be cured, though the first attempts to do so were very disappointing. Patients
with pulmonary tuberculosis, too gravely ill for any surgical procedures to be
contemplated, could now be so improved that surgery could be carried out with
success. Patients who would have required surgery could now be cured without
operation. But many difficulties were discovered when it was first introduced.
Various disagreeable side effects began to occur, notably deafness and dizziness.
The greatest problem in the early days, however, was the toleration which the
tubercle bacillus developed, to the extent that streptomycin -resistant organisms
began to appear. However, new chemical compounds were introduced and by
their use this problem was largely overcome.
Thefirstofthese, para-amino-salicyclic acid in 1946 had pre-dated streptomycin.
It was a relatively feeble remedy, difficult to take and with disagreeable side
effects. Better remedies were discovered: in 1953 isoniazid, in 1968 ethambutol,
in 1969 rifampicin. Though the necessity for sanatorium treatment no longer
exists, these most potent remedies must still be administered under the care of
experienced physicians. In the first instance the patient is admitted to a side ward
in a chest unit; when the bacilli disappear from the sputum - which may occur in
a few days - he is no longer infectious and can be treated at home.
One of the most distressing manifestations of tuberculosis was lupus vulgaris, as
tuberculous infection of the skin was called. This usually began between the ages
of 12 and 15. Women were affected more often than men. It most often started
in the mucous membrane inside the nose, and spread. The disease progressed
until the nose was quite eaten away, and the skin of.the whole face could become
affected. It was common about 60 years ago, when there were upwards of
100 such cases attending the Dermatological Department of the Royal Victoria
Hospital. At that time treatment was quite ineffective. The disfigurement was so
great that the unfortunate sufferers were often too ashamed of their revolting
appearance to venture out of their homes.
Applications of powerful ultra-violet light (called the Finsen light) sometimes
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in a few centres which had the special apparatus required. Then in the early
part of 1940 it was found, independently, by Charoy in Paris, and by Geoffrey
Dowling in London, that calciferol (Vitamin D2) in large doses caused remarkable
improvement; though the high doses sometimes caused kidney trouble,
especially in children. The use of calciferol was discontinued after the
introduction of streptomycin and the other modern drugs. This treatment has
been so successful that the condition has practically disappeared in this country,
though it is still seen in the immigrant population.
Tuberculosis today, though it has not disappeared from the community, is no
longer a problem. In 1984 in Northern Ireland there were 130 cases ofpulmonary
tuberculosis (8-2/100,000 pop.) and 43 cases of non-pulmonary tuberculosis
(2-7/100,000 pop.). The corresponding figures for England and Wales were
4,871 cases of pulmonary tuberculosis (9-8/1000,000 pop.) and 1,317 cases of
non-pulmonary tuberculosis (2-6/100,000 pop.). In Scotland the figures were
590 cases of pulmonary tuberculosis (11-5/100,000 pop.) and 151 cases of
non-pulmonary tuberculosis (2.9/100,000 pop.) and in the Republic of Ireland
the figures were 711 cases of pulmonary tuberculosis (21-1/100,000 pop.) and
126 cases of non -pulmonary tuberculosis (3 6/1 00,000 pop.).
The hospitals under the care of the Northern Ireland Tuberculosis Authority have
been adapted for other uses. One, the Whiteabbey Sanatorium, is now a general
hospital; others have become general practitioners' hospitals or geriatric units. In
Armagh the Drumarg Hospital is used for handicapped children.
We have come a long way from the days when one in six of the citizens of Belfast
perished from consumption, and there may well come a time when tuberculosis
will vanish from thecommunity. Whenthat daycomes, thework thattheNorthern
Ireland Tuberculosis Authority did should not be forgotten.
It is appropriate to quote here from the Tuberculosis Survey report: 'In 1946,
20 people were dying in the Province from tuberculosis every week. In 1959 the
figure had been reduced to two. The legacy of this remarkable tuberculosis
organisation, thecreation ofwhich pre -dated the Northern Ireland Health Service,
can be seen in the fact thatthe incidenceoftuberculosis is now substantially lower
in the Province than in other parts of the British Isles'. Similarly, the Department
of Agriculture has achieved a situation where no cases of tuberculosis derived
from infected milk products have been identified in the Province for at least 10
years.
Though tuberculosis in Ulster is no longer a problem, it is far from defeated in
the rest of the world. Crofton in 1960 and Bulla in 1981 reviewed the world -wide
prevalence of tuberculosis. They came to the conclusion that there were at least
6,000,000 cases and that there were 400,000 deaths each year. Outside Ulster,
tuberculosis remains a major killer.
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